Citigroup
LUNG icon

Citigroup’s Pulmonx LUNG Stock Holding History

Citigroup’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,857
Closed -$3.69K – 6037
2026
Q1 		$3.69K Buy
2,857
+1,982
+227% +$3.27K ﹤0.01% 5324
2025
Q4 		$1.93K Sell
875
-2,443
-74% -$4.59K ﹤0.01% 5460
2025
Q3 		$5.38K Sell
3,318
-10,247
-76% -$21.4K ﹤0.01% 5212
2025
Q2 		$35.1K Sell
13,565
-13,893
-51% -$54.8K ﹤0.01% 4920
2025
Q1 		$185K Sell
27,458
-2,892
-10% -$20.5K ﹤0.01% 4250
2024
Q4 		$206K Buy
30,350
+1,465
+5% +$9.65K ﹤0.01% 4394
2024
Q3 		$239K Buy
28,885
+20,467
+243% +$148K ﹤0.01% 4224
2024
Q2 		$53.4K Buy
8,418
+2,118
+34% +$16.3K ﹤0.01% 4542
2024
Q1 		$58.4K Buy
6,300
+982
+18% +$11.5K ﹤0.01% 4546
2023
Q4 		$67.8K Buy
5,318
+5,053
+1,907% +$52.6K ﹤0.01% 4381
2023
Q3 		$2.74K Sell
265
-11,726
-98% -$136K ﹤0.01% 4880
2023
Q2 		$157K Sell
11,991
-52,004
-81% -$636K ﹤0.01% 4012
2023
Q1 		$715K Buy
63,995
+19,133
+43% +$189K ﹤0.01% 2836
2022
Q4 		$378K Buy
44,862
+43,658
+3,626% +$415K ﹤0.01% 3353
2022
Q3 		$20K Sell
1,204
-1,633
-58% -$30.1K ﹤0.01% 4744
2022
Q2 		$42K Buy
2,837
+1,252
+79% +$25.8K ﹤0.01% 4608
2022
Q1 		$39K Sell
1,585
-5,504
-78% -$142K ﹤0.01% 4840
2021
Q4 		$227K Buy
7,089
+3,098
+78% +$113K ﹤0.01% 4291
2021
Q3 		$144K Buy
3,991
+2,416
+153% +$95.1K ﹤0.01% 4270
2021
Q2 		$69K Buy
1,575
+805
+105% +$35.1K ﹤0.01% 4666
2021
Q1 		$35K Sell
770
-1,416
-65% -$81.2K ﹤0.01% 4912
2020
Q4 		$151K Buy
+2,186
New +$107K ﹤0.01% 5204

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Citigroup's LUNG Position: Q2 2026 in Review

Citigroup sold out of Pulmonx (LUNG) in Q2 2026, closing a stake of 2,857 shares — an estimated $3.69K sold.

Citigroup first reported a position in LUNG in Q4 2020 and held it in 22 quarters. The position peaked at $715K in Q1 2023. 108 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

  • Citigroup reported no remaining Pulmonx position as of Q2 2026 after selling out during the quarter.
  • Citigroup sold 2,857 Pulmonx shares in Q2 2026, an estimated $3.69K.
  • Citigroup first reported a position in Pulmonx in Q4 2020 and held it in 22 quarters.
  • Citigroup's Pulmonx position peaked at $715K in Q1 2023.
  • 108 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.